The differential capability to promote in vitro endothelial cell proliferation was correlated with the presence and level of a variety of cytokines, analysed with the multiplex technology, and, for the HF patients, with relevant clinical parameters, such as NTpro-BNP levels and occurrence of cardiovascular events in the follow-up. This evidence concerns the gene NPPB and hydrops fetalis.